Guardant Health (MEX:GH) FCF Margin %: -23.60% (As of Mar. 2026)


MEX:GH Guardant Health Inc MEX:GH
67 GF Score
Price MXN2,080.00
GF Value MXN879.06
! 4 Warning Signs
View Full Analysis

What is Guardant Health FCF Margin %?

Guardant Health MEX:GH 67 FCF Margin % is -23.60% as of Mar. 2026. GuruFocus rates MEX:GH with a GF Score™ of 67/100 and a GF Value™ of MXN879.06. The stock has 4 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Guardant Health ranks worse than 66.18% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Guardant Health's Free Cash Flow for the three months ended in Mar. 2026 was MXN-1,284 Mil. Guardant Health's Revenue for the three months ended in Mar. 2026 was MXN5,440 Mil. Therefore, Guardant Health's FCF Margin % for the quarter that ended in Mar. 2026 was -23.60%.

As of today, Guardant Health's current FCF Yield % is -1.25%.

The historical rank and industry rank for Guardant Health's FCF Margin % or its related term are showing as below:

MEX:GH' s FCF Margin % Range Over the Past 10 Years
Min: -162.95   Med: -68.64   Max: -21.99
Current: -21.99


During the past 10 years, the highest FCF Margin % of Guardant Health was -21.99%. The lowest was -162.95%. And the median was -68.64%.

MEX:GH's FCF Margin % is ranked worse than
66.18% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: -1.845 vs MEX:GH: -21.99


Guardant Health FCF Margin % Related Terms


Guardant Health FCF Margin % Historical Data

* Premium members only.

The historical data trend for Guardant Health's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guardant Health FCF Margin % Chart

Guardant Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -76.02 -86.07 -61.26 -37.20 -23.73

Guardant Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -33.00 -28.41 -17.26 -19.28 -23.60

MEX:GH vs LH, DGX, MEDP: FCF Margin % Comparison

For the Diagnostics & Research subindustry, Guardant Health's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guardant Health FCF Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Guardant Health's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Guardant Health's FCF Margin % falls into.


MEX:GH
67GF Score
Guardant Health Inc MEX:GH
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guardant Health FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Guardant Health's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-4196.516/17681.976
=-23.73 %

Guardant Health's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-1283.982/5439.834
=-23.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -23.60% mean?
Guardant Health (MEX:GH) has a FCF Margin % of -23.60% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Guardant Health and its competitors. According to the industry distribution chart, Guardant Health ranks #135 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 66.2%.
Is Guardant Health's FCF Margin % too high?
Guardant Health's current FCF Margin % is -23.60%. Based on the distribution chart, Guardant Health ranks #135 out of 204 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Guardant Health has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does Guardant Health's FCF Margin % compare to LH and DGX?
According to the Medical Diagnostics & Research industry distribution chart, Guardant Health ranks #135 out of 204 companies for FCF Margin %. This places Guardant Health in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Diagnostics & Research company?
A good FCF Margin % depends on the Medical Diagnostics & Research industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Guardant Health and its competitors. Guardant Health's current FCF Margin % is -23.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guardant Health stock overvalued right now?
Guardant Health (MEX:GH) has a current FCF Margin % of -23.60%. The stock's GF Value™ is MXN879.06, compared to a current price of MXN2,080.00 — trading 136.6% above its estimated fair value. The current FCF Margin % is -23.60%. Guardant Health's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Guardant Health (MEX:GH), the current FCF Margin % is -23.60% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guardant Health (MEX:GH) Overvalued in 2026?

Based on GuruFocus' analysis, Guardant Health stock appears to be overvalued. The current stock price of MXN2,080.00 is trading 136.6% above its estimated GF Value™ of MXN879.06.

Key valuation signals for MEX:GH:

  • FCF Margin %: -23.60%
  • GF Value™: MXN879.06 vs. price of MXN2,080.00 (136.6% above fair value)
  • GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the MEX:GH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Guardant Health Business Description

Other Exchanges GH:USA1GH:Italy5GH:Germany
Address 3100 Hanover Street, Palo Alto, CA, USA, 94304
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
67GF Score

Get the complete analysis for MEX:GH

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN2,080.00
Price
MXN879.06
GF Value